- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | Genome editing offers hope for genetic hearing loss | ||
| Do | Amivantamab plus lazertinib shows survival benefit in lung cancer | ||
| Mi | Nouscom reveals promising results for lynch syndrome immunotherapy | ||
| Mo | WHO adds first maternal RSV vaccine to prequalification list | ||
| 20.03. | UK expands mandatory infectious disease reporting requirements | ||
| 19.03. | Orca Bio's T-cell therapy shows promise in haematological malignancies | ||
| 18.03. | UKHSA announces new effort to tackle hepatitis C | ||
| 17.03. | Anocca announces authorisation pancreatic cancer trial | ||
| 17.03. | Careology and Entia join forces to transform cancer care | ||
| 13.03. | Rxulti approved in the European Union for adolescent schizophrenia | ||
| 13.03. | Grifols clinical trial shows positive results for post-polio patients | ||
| 12.03. | Minoryx doses first patient with leriglitazone in Rett syndrome study | ||
| 12.03. | Orphelia Pharma explores other pathways for paediatric cancer treatment | ||
| 11.03. | Dementia drug neflamapimod shows positive phase 2b trial results | ||
| 11.03. | New weight-loss pill shows promising results | ||
| 10.03. | Agomab announces positive phase 2a interim results for AGMB-129 | ||
| 10.03. | Pfizer's Talzenna therapy accepted for use within NHS Scotland | ||
| 06.03. | Leqembi enters second consultation period following NICE draft guidance update | ||
| 06.03. | NHS patients receive UK-donated plasma medicines for first time in 30 years | ||
| 05.03. | SECuRE trial pre-chemo participants experience PSA level drops | ||
| 05.03. | Rotherham NHS Foundation Trust enhances patient engagement | ||
| 04.03. | Centauri therapeutics selects first ABX-01 clinical candidate | ||
| 03.03. | Blood cancer patients face treatment access disparity | ||
| 27.02. | Datapharm collaborates with VIDAL to improve medicines information access in France | ||
| 27.02. | Brainomix partners with Medtronic to enhance stroke care |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
